Nimotop (Nimodipine) – Patient Information for the UK

Nimotop contains nimodipine, a medicine from the calcium channel blocker (CCB) group. It is used to help reduce the risk of certain complications related to blood vessel spasms in the brain. This guide is written in patient-friendly language to help you understand how Nimotop works, how it is taken, and what to watch for.

Note: Always follow the instructions given by your healthcare professional and the medicine label. If you have questions about your particular situation, speak to your clinician or pharmacist.

Basic product information

How Nimotop works (mechanism of action)

Nimodipine blocks “L-type” calcium channels in the walls of blood vessels, particularly in the brain. Calcium entry into vascular smooth muscle helps blood vessels contract. By blocking these channels, nimodipine tends to relax blood vessels and may help to reduce or prevent narrowing (vasospasm).

After a subarachnoid haemorrhage (SAH), blood vessels in the brain can go into spasm as part of the healing process. These spasms can restrict blood flow and contribute to delayed brain injury. Nimotop is used to lower the risk of this type of complication.

Pharmacokinetics (what the body does to nimodipine)

Pharmacokinetics describes absorption, distribution, metabolism and elimination.

• Absorption: Nimodipine is absorbed from the gastrointestinal tract, but it can be variable from person to person.
• Distribution: It distributes into body tissues and can reach the brain.
• Metabolism: Nimodipine is extensively metabolised by the liver (primarily via CYP enzymes).
• Elimination: The drug and its metabolites are cleared mainly via the liver/bile and through metabolic pathways.
• Implication for interactions: Because metabolism involves liver enzymes, drugs that affect these pathways can alter nimodipine levels.

In practice, this means your medicine may be more strongly or less strongly effective (or more likely to cause side effects) if it is taken alongside certain interacting medicines or substances.

Typical use in the UK

In the UK, Nimotop is used to help reduce the risk of delayed ischaemic neurological deficit following subarachnoid haemorrhage due to a ruptured aneurysm (where appropriate). The goal is to protect the brain from reduced blood flow that can occur days after the bleeding event.

It is not a painkiller and is not used to “treat a stroke” in the same way as many emergency stroke medicines. Instead, it is used for prevention of a specific complication after a particular type of bleeding.

When to take Nimotop (timing and schedule)

Timing depends on the treatment plan and the medicine presentation. Follow your label or clinician’s instructions precisely.

• Consistency matters: Try to take doses at roughly the same times each day.
• Do not change the schedule: If you miss a dose, do not double up. Ask your pharmacist what to do.
• Course length: Treatment after SAH is typically given over a set period as advised by the care team.

Practical tip: Using a pill organiser or phone reminder can help you avoid missed doses—especially during longer treatment schedules.

Food interactions

Food can sometimes affect absorption of medicines. For nimodipine, the interaction is not always straightforward, so check your specific package instructions.

• General approach: If you are told to take it with food, follow that advice consistently.
• Grapefruit and grapefruit juice: Avoid or limit grapefruit products, as they can increase levels of certain calcium channel blockers by affecting liver enzymes.
• High-alcohol drinks taken with meals: Alcohol can also interact with nimodipine (see below).

If you’re unsure whether to take your version of Nimotop with or without food, ask your pharmacist for guidance based on your exact product.

Alcohol interactions

Alcohol may increase the risk of side effects such as dizziness or low blood pressure when taken with nimodipine (a medicine that can lower blood pressure).

• Avoid heavy drinking: Try to avoid large amounts of alcohol.
• Be cautious if you feel light-headed: If you experience dizziness, you should avoid alcohol and seek advice.
• Ask if unsure: If you drink regularly or have liver disease, speak to your pharmacist or clinician.

Medicine interactions (important)

Some medicines can change nimodipine levels or increase side effects. Always tell your healthcare professional about:

• All prescription medicines
• Over-the-counter medicines
• Herbal products and supplements

Examples of medicines that may interact

• Strong enzyme inhibitors: Medicines that inhibit liver metabolism can increase nimodipine exposure, raising the risk of side effects (for example, some antifungal or antibiotic medicines).
• Enzyme inducers: Some medicines can reduce nimodipine levels, potentially reducing effectiveness.
• Other blood pressure–lowering medicines: Combined effect can increase risk of low blood pressure, dizziness, and fainting.
• Antiarrhythmics and medicines affecting the heart: Some combinations may affect heart rate or rhythm.
• Other calcium channel blockers: Additional CCB effects can compound side effects.

What to do

• Check before starting: If you are prescribed a new medicine, confirm it is safe to take with Nimotop.
• Report symptoms: Seek advice if you notice fainting, severe dizziness, or a marked change in heart rate.

This is not a complete list. Interaction checks should be individualised by a healthcare professional using your full medicine list.

Indications: when Nimotop is used

The key indication for nimodipine (Nimotop) is the prevention of delayed ischaemic neurological deficit in adults following subarachnoid haemorrhage, where appropriate. Your specialist team will decide whether Nimotop is suitable for your situation based on the cause and severity of the bleeding and your overall health.

Dosing: general information

Dosing should be individualised. Only take Nimotop as directed by your clinician for your prescribed regimen.

• Do not alter dose or stop early: Nimotop is often used as a time-limited preventive course.
• Follow the schedule on your label: The exact number of doses per day and the duration may differ by treatment setting.

If you have been given Nimotop for SAH: a hospital or specialist team usually provides a carefully monitored regimen. During such treatment, blood pressure and symptoms are commonly reviewed.

Safety profile: side effects and what to watch for

Like all medicines, Nimotop can cause side effects. Not everyone will experience them. Side effects can be more likely early in treatment or if doses are missed/changed, or when interacting medicines are taken.

Common side effects

• Low blood pressure (hypotension): may cause dizziness or feeling faint
• Headache
• Flushing
• Swelling (oedema), especially in the lower limbs
• Nausea

Less common but important side effects

• Palpitations (awareness of heartbeat)
• Bradycardia (slow heart rate) or other heart rhythm effects
• Worsening dizziness, fainting, or severe weakness
• Changes in liver function tests (rare; your clinician may monitor if relevant)

Seek urgent medical help if

• You faint or feel you might faint despite resting
• You develop severe dizziness, chest pain, or shortness of breath
• Signs of an allergic reaction occur, such as facial swelling, trouble breathing, or widespread rash

Practical use tips (patient-friendly)

• Take as directed: Use the exact schedule provided.
• Stay hydrated appropriately: Dehydration can worsen dizziness, especially with medicines that lower blood pressure.
• Stand up slowly: If you feel light-headed, take care when moving from lying or sitting to standing.
• Avoid grapefruit products: This can increase blood levels of certain calcium channel blockers.
• Keep a medicine list: Include OTC and supplements to help prevent interactions.
• Monitor symptoms: Note dizziness, headaches, flushing, or swelling—especially during dose changes or early treatment.

If you are taking Nimotop in a clinical setting, staff may monitor your blood pressure and other parameters more closely.

Alternative options

Alternative treatments depend on the underlying condition (for example, the management of SAH) and the overall clinical plan.

Medicines that may be considered

• Other calcium channel blockers: Some clinicians may consider alternatives depending on local guidance and patient factors.
• Supportive strategies for preventing vasospasm: These may include careful fluid management and other interventions as determined by the specialist team.

Non-medicine approaches

• Close monitoring: Neurological and vital sign monitoring is a key part of SAH care.
• Addressing risk factors: Lifestyle factors and overall patient stability are considered alongside medication.

Your specialist will select the most appropriate option for your specific condition. Do not self-switch between calcium channel blockers without advice.

Market and legal context in the United Kingdom

In the UK, medicines are regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) and must meet quality, safety and labelling standards. Nimotop (nimodipine) is a long-established medicine used in the management of complications following SAH, and availability can vary by supplier and formulation.

When purchasing medicines online, ensure you use a legitimate UK-registered pharmacy or online pharmacy service that complies with UK regulations. Products should be supplied with clear labelling, patient information leaflets, and appropriate batch/expiry details.

Recent guidance and monitoring considerations

Clinical management of subarachnoid haemorrhage continues to evolve, with ongoing emphasis on:

• Timely assessment and prevention of delayed cerebral ischaemia
• Vasospasm monitoring and supportive care
• Medication review for interactions and blood pressure effects

Guidance may be updated by organisations such as the National Institute for Health and Care Excellence (NICE) and specialist bodies, as well as by local hospital protocols. If you are taking Nimotop, your care team will apply the most current protocol relevant to your situation.

Delivery and availability (online pharmacy information)

Availability of Nimotop can depend on stock levels and the exact product strength/formulation. Delivery options vary by supplier and may include standard and express shipping.

• Check product details: Confirm the strength, pack size and form before ordering.
• Delivery times: These vary by location and courier; estimated delivery dates are usually shown at checkout.
• Cold chain: Nimodipine products do not typically require refrigeration, but always follow storage instructions on the packaging.
• Packaging integrity: Only accept medicines with intact packaging and readable expiry/batch information.

If an item is out of stock, many pharmacies offer:

• Backorder/pre-order options
• Alternative product suggestions (same active ingredient may differ by brand/form)
• Estimated restock dates

FAQ – Nimotop (nimodipine)

1. What is Nimotop used for?

Nimotop (nimodipine) is used to help prevent delayed ischaemic neurological deficits after subarachnoid haemorrhage, where appropriate.

2. How long will I need to take it?

Treatment duration depends on your clinical plan. If it is being used after SAH, courses are typically time-limited and closely managed by specialist teams.

3. When should I take Nimotop?

Follow your label or clinician’s instructions. Taking doses at the same times each day can help maintain steady medicine exposure.

4. Can I take Nimotop with food?

Food effects can vary. Some instructions may recommend taking with or without food depending on the formulation. Check the patient leaflet for your exact product and ask your pharmacist if unsure.

5. Can I drink alcohol while taking Nimotop?

It’s best to limit or avoid alcohol. Alcohol can increase the chance of side effects such as dizziness or low blood pressure.

6. What should I do if I miss a dose?

Do not double up. Contact your pharmacist for advice based on your dosing schedule and how long it has been since the missed dose.

7. Are there any foods or drinks I should avoid?

Avoid grapefruit and grapefruit juice, as it can increase exposure to some calcium channel blockers.

8. What side effects are most common?

Common side effects include low blood pressure, headache, flushing, swelling, and nausea.

9. When should I seek urgent help?

Seek urgent medical help if you faint, have severe dizziness, chest pain, trouble breathing, or signs of an allergic reaction.

10. Can I take other medicines with Nimotop?

Some medicines can interact with nimodipine. Tell your pharmacist or healthcare professional about all medicines and supplements you take before starting Nimotop, and ask before starting new products.

11. Is Nimotop suitable for everyone?

Suitability depends on your medical history, other medicines, and your overall risk profile. Your clinician will consider factors such as blood pressure, liver function, and potential interactions.

Summary

Nimotop (nimodipine) is a calcium channel blocker used to reduce the risk of certain delayed neurological complications following subarachnoid haemorrhage. It works by relaxing blood vessels in the brain and may help counter the effects of vasospasm. Because nimodipine can affect blood pressure and is metabolised in the liver, it’s important to follow the dosing schedule and check interactions—including alcohol and grapefruit products. If you experience significant dizziness, fainting, or any signs of an allergic reaction, seek urgent medical advice.